Skip to main content
HR 6980 117th Congress House Health

To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

Introduced: March 8, 2022 Introduced by: Hudson, Richard Republican · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2022
Referred to the Subcommittee on Health.
Mar 8, 2022
Referred to the House Committee on Energy and Commerce.
Mar 8, 2022
Introduced in House
 Plain-English summary Congressional Research Service

This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.

What's happening now March 9, 2022

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2